Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Indian share markets open firm
Wed, 15 May 09:30 am

Asian stock markets have opened the day on a mixed note with China (down 0.1%) and South Korea (down 0.1%) trading weak. However, markets in Japan (up 2.3%) and Hong Kong (up 0.5%) are trading firm. The Indian share markets indices have also opened the day on a firm note. Stocks in the realty, auto and banking space are leading the gains.

The Sensex today is up by around 122 points (0.6%), while the NSE-Nifty is up by around 30 point (0.5%). Mid and small cap stocks are also trading in the green with the BSE Mid Cap and BSE Small Cap indices up by around 0.6% and 0.4% respectively. The rupee is trading at Rs 54.76 to the US dollar.

Indian pharma stocks have opened the day on a firm note with Elder Pharma, Glenmark Pharma and Lupin Ltd leading the gains. Indian pharma firm Dr Reddy's Laboratories has announced its financial results for the quarter ended March 2013. The company's revenues grew by 25.6% year-on-year (YoY) from Rs 26.6 bn in 4QFY12 to Rs 33.4 bn in 4QFY13. The growth was driven by strong sales from North America and emerging markets in the global generics segment. The pharmaceutical services and active ingredients segments also witnessed better performance. At the bottomline level, net profits increased by 66.6% YoY from Rs 3.4 bn in 4QFY12 to Rs 5.7 bn in 4QFY13. For the financial year ended March 2013 (FY13) revenues were higher by 20% YoY at Rs 116.3 bn while net profits increased by 17.6% YoY.

Auto stocks have opened the day on a firm note with Eicher Motor, Maruti Suzuki and Hero MotoCorp leading the gains. As per a leading financial daily, India's leading two-wheeler manufacturer Hero MotoCorp has entered into the Central American market. It has partnered with Indy Motos Group of Guatemala and launched its two-wheelers in Guatemala, El Salvador and Honduras. In Central America, the company has introduced bikes such as Hunk, Karizma, Glamour, HF Dawn, Splendor NXG, Super Splendor and Achiever under the Hero brand. As per the company's Managing Director and CEO Mr Pawan Munjal, the company is also planning to enter other markets in Latin and Central America and Africa. It is worth noting that the company aims to achieve 10% of its volume sales from international business in the next four to five years.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian share markets open firm". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.